Publikationsserver
Combined Minimally Invasive Mitral Valve Surgery and Percutaneous Coronary Intervention: A Hybrid Concept for Patients with Mitral Valve and Coronary Pathologies
We evaluated the feasibility of hybrid percutaneous coronary intervention (PCI) and minimally invasive mitral valve surgery (MIMVS) in patients with concomitant coronary and mitral disease. Of 534 patients who underwent MIMVS at our institution between 2012 and 2018, those with combined mitral an...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
Philipps-Universität Marburg
2023
|
| Ábhair: | |
| Rochtain ar líne: | An téacs iomlán mar PDF |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
| Achoimre: | We evaluated the feasibility of hybrid percutaneous coronary intervention (PCI) and minimally
invasive mitral valve surgery (MIMVS) in patients with concomitant coronary and mitral
disease. Of 534 patients who underwent MIMVS at our institution between 2012 and 2018, those
with combined mitral and single vessel coronary pathologies who underwent MIMVS and PCI were
included. Patients were excluded if they had endocarditis or required emergency procedures. Preprocedural,
procedural, and postprocedural data were retrospectively analyzed. In total, 10 patients
(median age, 75 years; 7 males) with a median ejection fraction (EF) of 60% were included. Nine
patients underwent PCI before and one after MIMVS. The success rate was 100% in both procedures.
There were no postoperative myocardial infarctions or strokes. Two patients developed delirium and
one required re-thoracotomy for bleeding. The median stay in intensive care and the hospital was 3
and 8 days, respectively. The 30-day survival rate was 100%. A hybrid PCI and MIMVS approach is
feasible in patients with mitral valve and single vessel coronary disease. In combined pathologies,
the revascularization strategy should be evaluated independent from the mitral valve pathology in
the presence of MIMVS expertise. Extension of this recommendation to multivessel disease should be
evaluated in future studies. |
|---|---|
| Cur síos ar an mír: | Gefördert durch den Open-Access-Publikationsfonds der UB Marburg. |
| DOI: | 10.3390/jcm12175553 |